Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours.
Jigang ChenXin LiangXin TongMingyang HanLinjin JiSongfeng ZhaoZhiqiang HuAihua LiuPublished in: Journal of neurointerventional surgery (2022)
For patients with AIS with a time of onset between 4.5 and 9 hours, perfusion imaging-guided intravenous alteplase was likely to be cost-effective in China and was cost-effective in the US when compared with placebo.
Keyphrases
- acute ischemic stroke
- high dose
- high resolution
- atrial fibrillation
- contrast enhanced
- low dose
- magnetic resonance imaging
- clinical trial
- randomized controlled trial
- computed tomography
- magnetic resonance
- mass spectrometry
- fluorescence imaging
- brain injury
- cerebral ischemia
- blood brain barrier
- subarachnoid hemorrhage